Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phage Therapy in Patients With Hip or Knee Prosthetic Joint Infection Due to Staphylococcus Aureus
NCT06605651Phase 2Not yet recruiting
- Sponsor
- Phagenesis
- Start
- Jul 2026
- Primary completion
- Mar 2028
- Modality
- Single Strain Products, Multi-strain Products
01
Overview
A Phase 2 trial of PP1493 + PP1815 in prosthetic joint infection (PJI), sponsored by Phagenesis. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
PP1493 + PP1815
03
Conditions
prosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT06605651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06605651.